Keywords: Neuro, Brain, metabolism, development
Motivation: N-acetyl-aspartyl-glutamate (NAAG) is a dipeptide and glutamate neuromodulator with possible significance as therapeutical target for injuries and diseases associated with glutamate neurotoxicity.
Goal(s): Determine age-dependent differences in its accumulation in white and grey matter in the human brain.
Approach: Existing MR spectra from 410 “closest-to-normal” pediatric patients and controls were evaluated.
Results: NAAG concentrations in the human brain were low and borderline detectable from birth to early childhood but then increased in late childhood in the parietal white matter whereas NAAG remained low in parietal grey matter.
Impact: This study demonstrates that NAAG accumulates at late childhood predominantly in WM. Furthermore, it suggests that in vivo MRS can be used to assess NAAG levels in disorders associated with excessive glutamatergic neurotransmission, such as childhood seizures.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords